Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)

29 Apr 2016

Abstract excerpt

Measuring the severity and progression of facioscapulohumeral muscular dystrophy (FSHD) is particularly challenging because muscle weakness progresses over long periods of time and can be sporadic. Biomarkers are essential for measuring disease burden and testing treatment strategies. We utilized the sensitive, specific, high-throughput SomaLogic proteomics platform of 1129 proteins to identify proteins with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Genetic Neurodegenerative Diseases
Share to Muscle Physiology and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27185459
DOI: 10.1016/j.nmd.2016.04.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)PMID 27185459Read ↗

Emerging proteomic biomarkers of X-linked muscular dystrophySemantic proximity Read ↗

Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular DystrophySemantic proximity Read ↗

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.Semantic proximity Read ↗

A Journey with LGMD: From Protein Abnormalities to Patient Impact.Semantic proximity Read ↗

Circulating Biomarkers for Duchenne Muscular DystrophySemantic proximity Read ↗

Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditionsSemantic proximity Read ↗

Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical applicationSemantic proximity Read ↗

Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophiesSemantic proximity Read ↗

Proteomic profiling uncovers sexual dimorphism in the muscle response to wheel running exercise in the FLExDUX4 murine model of facioscapulohumeral muscular dystrophySemantic proximity Read ↗

Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle FunctionSemantic proximity Read ↗

The Muscular DystrophiesSemantic proximity Read ↗

Large-scale Proteomics Profiling of Peripheral Blood of DM1 patients identifies biomarkers for disease severity and functional capacitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.